Brief: TransCode Therapeutics Appoints John Tattory As Interim CFO
10/09/2026 21:26
BRIEF-TransCode Therapeutics Appoints John Tattory As Interim CFO Sept 10 (Reuters) - Transcode Therapeutics Inc RNAZ.O:
TRANSCODE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION
TRANSCODE THERAPEUTICS - TOM FITZGERALD ANNOUNCES RETIREMENT AS CHIEF FINANCIAL OFFICER
TRANSCODE THERAPEUTICS - APPOINTS JOHN TATTORY AS INTERIM CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY
Source text: ID:nPn8hCbgDa
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors